Publication

Somatostatin analogs for pancreatic neuroendocrine tumors: is there any benefit when Ki-67 Is >= 10%?

Merola, E
; 
Gordoa, TA
; 
Zhang, P
; 
Al-Toubah, T
; 
Pelle, E
; 
Liu, M
; 
Laskaratos, F
; 
de Mestier, L
; 
Lamarca, Angela
; 
Hernando, J
... show 2 more
Citations
Altmetric:
Abstract
Authors
Merola, E
Gordoa, TA
Zhang, P
Al-Toubah, T
Pelle, E
Liu, M
Laskaratos, F
de Mestier, L
Lamarca, Angela
Hernando, J
Cives, M
van Leeuwaarde, R
Affiliation
Azienda Provinciale per i Servizi Sanitari (APSS), Trento, Italy
Description
Date
2020
Publisher
Collections
All Christie Publications
Load more
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Merola E, Gordoa T, Zhang P, Al-Toubah T, Pelle E, Liu M, et al. Somatostatin analogs for pancreatic neuroendocrine tumors: is there any benefit when Ki-67 Is >= 10%? Neuroendocrinology. 2020;110:197-
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/622988
Embedded videos